Search

everythinglearnresearchcommunity

for

Search:↓

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Tinea incognito in Iran commonly affects adults and mimics other skin conditions.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

Women who had bariatric surgery risk nutritional deficiencies causing skin issues during pregnancy and breastfeeding.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

TNF-alpha inhibitors can cause various immune-related skin issues.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

The document concludes that secondary syphilis cases are increasing and often misdiagnosed, pityriasis rubra pilaris can be distinguished from psoriasis by skin cell features, and different skin layers produce specific components during skin repair.

Antibiotics often cause skin reactions, making them a major health concern.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

The document is a detailed medical reference on skin and genetic disorders.

Targeted cancer therapies often cause serious skin problems that need careful management.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.